Jonathan Basil Fitzgerald,Ashish Kalra,Shannon Leonard,Stephan Braun,Bin Zhang
申请号：
US16346436
公开号：
US20200030302A1
申请日:
2017.11.01
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil are useful in the treatment of gastric cancer, including treatment of patients diagnosed with previously untreated gastric cancer. The combination therapy can include the administration of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.
